Jianzhijia Pharmaceutical Chain Group Co., Ltd.

SHSE:605266 Stock Report

Market Cap: CN¥4.1b

Jianzhijia Pharmaceutical Chain Group Past Earnings Performance

Past criteria checks 2/6

Jianzhijia Pharmaceutical Chain Group has been growing earnings at an average annual rate of 13%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 22.2% per year. Jianzhijia Pharmaceutical Chain Group's return on equity is 8.5%, and it has net margins of 2.5%.

Key information

13.0%

Earnings growth rate

5.7%

EPS growth rate

Consumer Retailing Industry Growth12.8%
Revenue growth rate22.2%
Return on equity8.5%
Net Margin2.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Further Upside For Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Could Introduce Price Risks After 33% Bounce

Nov 12
Further Upside For Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Could Introduce Price Risks After 33% Bounce

We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt

Oct 03
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt

What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?

Jul 16
What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?

Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%

Jun 19
Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%

Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet

Feb 27
Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet

Revenue & Expenses Breakdown

How Jianzhijia Pharmaceutical Chain Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:605266 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249,3162372,8970
30 Jun 249,2283192,8010
31 Mar 249,2283902,7060
31 Dec 239,0814142,5860
30 Sep 239,3054572,5790
30 Jun 238,8464422,4280
31 Mar 238,2314192,2750
31 Dec 227,5143742,1250
30 Sep 226,2773001,8440
30 Jun 225,8622681,7140
31 Mar 225,5182671,5880
31 Dec 215,2353011,4780
30 Sep 214,9472761,3820
30 Jun 214,7372621,3090
31 Mar 214,5782621,2300
31 Dec 204,4662511,1880
30 Sep 204,2132151,0980
31 Dec 193,5291689950
31 Dec 182,7661348320
31 Dec 172,347957120
31 Dec 162,054716700
31 Dec 151,844186340
31 Dec 141,667175620

Quality Earnings: 605266 has high quality earnings.

Growing Profit Margin: 605266's current net profit margins (2.5%) are lower than last year (4.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 605266's earnings have grown by 13% per year over the past 5 years.

Accelerating Growth: 605266's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 605266 had negative earnings growth (-48.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).


Return on Equity

High ROE: 605266's Return on Equity (8.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 11:46
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jianzhijia Pharmaceutical Chain Group Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hao WuChasing Securities
Hui LiuChina Galaxy Securities Co., Ltd.
Kehan MengHaitong International Research Limited